Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoviderm vs Connettivina for Superficial Burns
NCT05805917Unknown
- Sponsor
- Istituto Ganassini
- Start
- Apr 2023
- Primary completion
- Sep 2023
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Istituto Ganassini. Primary endpoint: Reduction in skin tension at 14 days. Status: unknown.
Beyond the preview
Go deeper on NCT05805917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05805917.